← 返回

单细胞多组学揭示多发性骨髓瘤中 CAR-T 细胞持久性与功能障碍的调控机制

英文原题:Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.

查看英文原题

Single-cell multiomics reveals regulatory mechanisms of CAR T-cell persistence and dysfunction in multiple myeloma.

PubMed 2026/02/05(内容时间) Blood Neoplasia

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

理解驱动多发性骨髓瘤(MM)中嵌合抗原受体(CAR)T细胞功能和持续存在的机制,仍是改善治疗结局的关键挑战。在本研究中,我们应用单细胞多组学和基因调控网络分析,对MM患者纵向采集的骨髓(BM)和外周血(PB)样本中靶向B细胞成熟抗原的CAR-T 细胞的转录动态和克隆演化进行了表征。

我们的结果揭示,浸润BM的CAR-T 细胞比其PB对应细胞表现出更活化和耗竭的表型,关键转录调控因子驱动了这些变化。效应向记忆转换的失调导致终末分化CAR-T 细胞增多,与持续存在不良相关。

此外,我们在一名部分缓解患者BM中鉴定出一个高度扩增的CAR-T 细胞克隆,其特征为白细胞介素-10(IL-10)表达升高。功能分析表明,刺激内源性T细胞受体(TCR)增强了IL-10产生,可能促成了CAR-T 细胞增殖和持续存在受损。这些发现揭示了影响CAR-T 细胞动态的调控机制,为改善MM中CAR-T 细胞持续存在和治疗疗效提供了新见解,并突出了优化MM患者CAR-T 细胞治疗的潜在分子靶点。

展开英文摘要原文

Understanding the mechanisms that drive chimeric antigen receptor (CAR) T-cell function and persistence in multiple myeloma (MM) remains a critical challenge for improving therapeutic outcomes. In this study, we applied single-cell multiomics and gene regulatory network analysis to characterize the transcriptional dynamics and clonal evolution of B-cell maturation antigen-targeted CAR T-cells in longitudinally collected bone marrow (BM) and peripheral blood (PB) samples from patients with MM.

Our results revealed that CAR T cells infiltrating BM exhibited a more activated and exhausted phenotype than their PB counterparts, with key transcriptional regulators driving these changes. Dysregulation in the effector-to-memory transition led to increased presence of terminally differentiated CAR T-cells, correlating with poor persistence.

Additionally, we identified a hyperexpanded CAR T-cell clone in the BM of a patient in partial response, marked by elevated interleukin-10 (IL-10) expression. Functional analyses demonstrated that stimulation of endogenous T-cell receptor (TCR) enhanced IL-10 production, potentially contributing to impaired CAR T-cell proliferation and persistence.

These findings uncover regulatory mechanisms influencing CAR T-cell dynamics, offering new insights into improving CAR T-cell persistence and therapeutic efficacy in MM, and highlight potential molecular targets for optimizing CAR T-cell therapy in patients with MM.

论文信息

作者
Jordana-Urriza L、Serrano G、Camara-Peña S、Calleja-Cervantes ME、San Martin-Uriz P、Zabaleta A、Oliver-Caldes A、Español-Rego M
单位
Hemato-Oncology Program, Cima Universidad de Navarra, IdiSNA, Pamplona, Spain.Spain
期刊
Blood neoplasia2026 May
原文标识
PubMed 42027747 · DOI 10.1016/j.bneo.2026.100203